Clinical Trials · NCT01344564
Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Urology of Virginia
- Enrollment
- 50
- Start date
- Apr 2011
- Locations
- 1 site, United States
- Primary endpoint
- Testosterone measurement